Social Media Influencers Fueling Parallel Trade for Unlicensed Weight-Loss Drug

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users administering products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, populated with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

Within moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly serious health risks”.